AJMC April 20, 2022
Key opinion leaders addressed cost, accessibility, and other barriers limiting use of comprehensive genomic profiling (CGP), and how employers can help drive preventive care and precision medicine through CGP.
Closing the care gap in what is possible through genomic testing and current medical treatment warrants a collaborative approach beginning at the physician level and expanding to payers, delivery systems, and employers.
Randy Scott, PhD, executive co-chairman, Genomic Life, noted during the panel discussion, “Let’s Get Personal: The Power of Genomics,” that despite the rapid pace in which DNA sequencing technology has evolved in recent years, the use of genomic information remains underutilized to prevent, diagnose, or treat disease.
Issues such as a lack of physician training and cost/access barriers have...